{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:05Z","timestamp":1793134085077,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970705"],"award-info":[{"award-number":["81970705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000752"],"award-info":[{"award-number":["82000752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.humimm.2021.12.001","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T07:22:58Z","timestamp":1639812178000},"page":"144-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aberrant expression of inhibitory receptors on B cells in patients with Graves\u2019 disease"],"prefix":"10.1016","volume":"83","author":[{"given":"Yalei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoufeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9382","key":"10.1016\/j.humimm.2021.12.001_b0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"Cooper","year":"2003","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.humimm.2021.12.001_b0010","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves' disease","volume":"358","author":"Brent","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2021.12.001_b0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-11-0299","article-title":"A critical review and meta-analysis of the association between overt hyperthyroidism and mortality","volume":"165","author":"Brandt","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.humimm.2021.12.001_b0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni0901-769","article-title":"Determinants of autoimmune thyroid disease","volume":"2","author":"Weetman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/cei.12183","article-title":"The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes","volume":"147","author":"Van Der Weerd","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2021.12.001_b0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/ijlh.13541","article-title":"Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry","volume":"43","author":"Wang","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.humimm.2021.12.001_b0035","first-page":"11:606338","article-title":"Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses","volume":"18","author":"Ruschil","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12865-014-0028-1","article-title":"Memory B cell subsets and plasmablasts are lower in early than in long-standing Rheumatoid Arthritis","volume":"15","author":"Fedele","year":"2014","journal-title":"BMC Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2021.12.001_b0045","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1002\/art.30466","article-title":"B cell biomarkers of rituximab responses in systemic lupus erythematosus","volume":"63","author":"Vital","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2021.12.001_b0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40478-014-0138-2","article-title":"Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood","volume":"2","author":"Hohmann","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.humimm.2021.12.001_b0055","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.20011435","article-title":"Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and FcgammaRII-mediated B Cell Suppression","volume":"195","author":"Rudge","year":"2002","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.humimm.2021.12.001_b0060","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.4049\/jimmunol.1203366","article-title":"CD40 mediates downregulation of CD32B on specific memory B cell populations in rheumatoid arthritis","volume":"190","author":"Zhang","year":"2013","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2021.12.001_b0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.semarthrit.2013.11.010","article-title":"A regulatory role for CD72 expression on B cells in systemic lupus erythematosus","volume":"43","author":"Vadasz","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.humimm.2021.12.001_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2015.01.016","article-title":"The expression of Fc\u03b3 receptors in Hashimoto\u2019s thyroiditis","volume":"294","author":"Liu","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000363161","article-title":"Thyroid autoimmunity","volume":"26","author":"Wiersinga","year":"2014","journal-title":"Endocr Dev."},{"key":"10.1016\/j.humimm.2021.12.001_b0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/JPEM.2003.16.1.63","article-title":"Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases","volume":"16","author":"Bossowski","year":"2003","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.humimm.2021.12.001_b0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/imm.13306","article-title":"Netea-Maier, Thyrotrophin and thyroxine support immune homeostasis in humans","volume":"163","author":"Jaeger","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2021.12.001_b0090","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/eji.1830190805","article-title":"Fc gamma RII expression in resting and activated B lymphocytes","volume":"19","author":"Amigorena","year":"1989","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2021.12.001_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22904","article-title":"Decreased expression of Fc\u03b3RII in active Graves' disease patients","volume":"33","author":"Lu","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.humimm.2021.12.001_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40798-015-0011-2","article-title":"Response of oxidative stress and inflammatory biomarkers to a 12-week aerobic exercise training in women with metabolic syndrome","volume":"1","author":"Farinha","year":"2015","journal-title":"Sports Med Open."},{"key":"10.1016\/j.humimm.2021.12.001_b0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biopha.2004.04.005","article-title":"A role of FcgammaRIIB in the development of collagen-induced arthritis","volume":"58","author":"Nakamura","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2021.12.001_b0110","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.3389\/fimmu.2018.02814","article-title":"CD32 Ligation Promotes the Activation of CD4(+) T Cells","volume":"9","author":"Holgado","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2021.12.001_b0120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clim.2010.08.006","article-title":"Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis","volume":"137","author":"Prokopec","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1196\/annals.1422.020","article-title":"Altered expression of Fcgamma and complement receptors on B cells in systemic lupus erythematosus","volume":"1108","author":"Gergely","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.humimm.2021.12.001_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.614492","article-title":"Fc\u03b3RIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis","volume":"11","author":"Trend","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0140","article-title":"Differential transcriptome and development of human peripheral plasma cell subsets","volume":"4","author":"Garimalla","year":"2019","journal-title":"JCI Insight."},{"issue":"4","key":"10.1016\/j.humimm.2021.12.001_b0145","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4049\/jimmunol.1301361","article-title":"CD19 and CD32b differentially regulate human B cell responsiveness","volume":"192","author":"Karnell","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.12.001_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2016.11.004","article-title":"CD32b expression is down-regulated on double-negative memory B cells in patients with Hashimoto's thyroiditis","volume":"440","author":"Liu","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.humimm.2021.12.001_b0155","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/ar2985","article-title":"B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy","volume":"12","author":"Catal\u00e1n","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.humimm.2021.12.001_b0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.13615","article-title":"Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity","volume":"205","author":"Li","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2021.12.001_b0165","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.4049\/jimmunol.1500753","article-title":"A Reassessment of IgM Memory Subsets in Humans","volume":"195","author":"Bagnara","year":"2015","journal-title":"J. Immunol."},{"issue":"1-2","key":"10.1016\/j.humimm.2021.12.001_b0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08820139.2019.1688343","article-title":"Increases of CD80 and CD86 Expression on Peripheral Blood Cells and their Gene Polymorphisms in Autoimmune Thyroid Disease","volume":"49","author":"Watanabe","year":"2020","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.humimm.2021.12.001_b0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fendo.2020.00286","article-title":"Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism","volume":"12","author":"Abbara","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.humimm.2021.12.001_b0180","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.159.6.2712","article-title":"Primary B cell development is impaired in mice with defects of the pituitary\/thyroid axis","volume":"159","author":"Montecino-Rodriguez","year":"1997","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2021.12.001_b0185","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2567.2009.03138.x","article-title":"Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fc\u03b3 receptors and costimulatory molecules on dendritic cells","volume":"128","author":"Carre\u00f1o","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2021.12.001_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/609593","article-title":"Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy","volume":"2015","author":"Shen","year":"2015","journal-title":"Dis. Markers"},{"issue":"6-7","key":"10.1016\/j.humimm.2021.12.001_b0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/08916930310001603046","article-title":"Cytokines in Thyroid Autoimmunity","volume":"36","author":"Ajjan","year":"2003","journal-title":"Autoimmunity."},{"key":"10.1016\/j.humimm.2021.12.001_b0200","doi-asserted-by":"crossref","first-page":"202011086","DOI":"10.1073\/pnas.2011086117","article-title":"Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom","volume":"117","author":"Hamer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.humimm.2021.12.001_b0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11695-018-3479-2","article-title":"Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study","volume":"29","author":"Ooi","year":"2019","journal-title":"Obes. Surg."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:54:42Z","timestamp":1759319682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885921002834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0198885921002834"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2021.12.001","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant expression of inhibitory receptors on B cells in patients with Graves\u2019 disease","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}